The incidence of atrial fibrillation (AF) has increased significantly over the last decades. Population height is changing in many countries. Height is an important risk factor for AF. The aim of the present study was to assess the role of changes in population height in the increased risk of AF. 
Introduction
Incidence of atrial fibrillation (AF) has been increasing in Denmark and in many other parts of the world for several decades. [1] [2] [3] [4] [5] [6] [7] The causes of this increase are not known for certain, but various mechanisms have been proposed, including improved detection because of increasing awareness of AF in the health care system and increasing availability of electrocardiogram (ECG) recording and echocardiography. 8 Furthermore, ageing populations as well as increasing survival after heart attacks and heart failure (HF) have rendered more subjects susceptible to AF. 9, 10 Multiple risk factors for AF have been described: male sex, elevated blood pressure, life style in relation to alcohol use, tobacco, pulmonary function, physical exertion, social factors, heredity, anthropometric measures, inflammation, and more. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Stature is an important risk factor for AF. 12, [23] [24] [25] [26] [27] Height has increased significantly over the last century in many populations. 28 Average height among Danish men has increased by about 12 cm from 1911 to the present. 29 In women, increases in height have also occurred albeit to a smaller extend. 28 Even though final height is attained in young adulthood, and AF occurs mainly in middle-aged and elderly subjects, height is a stable characteristic and any effect of height is life-long. The possible effect of changes in population height on the epidemiology of AF is the theme of this study. We will analyse incident AF and AF risk factors in the Copenhagen City Heart Study, and we assess population attributable risk (PAR) in relation to AF incidence and risk factors for AF, in particular height.
Methods

Study population
The Copenhagen City Heart Study [30] [31] [32] is a prospective cardiovascular population study of men and women aged 20 and older, randomly sampled from Copenhagen, Denmark. Figure S1 describes the disposition of participants.
Statistical methods
Generalized estimation equations (GEE) logistic regression analysis with repeated measures and unstructured correlation structure with adjustment for age, age squared, sex, and survey number was performed. Prevalence and incidence rates were standardized according to the European standard population for people aged 20 or above. 33 Risk of incident AF was assessed by Fine and Gray's subdistribution hazards model with non-AF mortality as competing risk and censoring after 15 years of follow-up. In this model, a test for multiplicative interaction between sex, height, and incident AF was performed. A repeated measures analysis of the Fine-Gray model with robust variance estimator for treating subjects as clusters was carried out to test for a secular trend from survey 1 to 4. A test for multiplicative interaction between sex, survey number, and incident AF was additionally performed.
Multivariable adjusted Mantel-Haenszel PAR was calculated as PAR = p(exposurejevent)*(relative risk -1)/relative risk, where p(exposurejevent) is the prevalence of exposure among events. 34 Relative risks were estimated by the multivariable adjusted hazard ratios (HR) based on Fine and Gray's subdistribution hazards model. For overall PAR, binary covariates are needed. 34 Hence, for covariates with more than two categories, a single exposed category is formed by combining all exposed categories as one. The bias-corrected PARs and 95% confidence intervals (CI) were estimated by bootstrap resampling with 1000 samples. For the first survey, bootstrap resampling was not feasible due to small number of events. Instead, we plugged in the upper and lower limits of the 95% CI for the HR (Fine-Gray) in the formula for PAR. The multivariable models included the following covariates: height, sex, systolic blood pressure, blood pressure medication, smoking, forced expiratory volume in 1 second (FEV 1 ) percent predicted, years in school, leisure-time physical activity, alcohol intake, body mass index (BMI), previous admission for ischaemic heart disease (IHD) or HF, and diabetes.
The definitions of these covariates are found in Supplementary material online, Table S1 . For alcohol intake, there was a U-shaped relationship with risk of AF in all four surveys both in univariate and multivariable models. Hence, we choose to combine never/almost never and daily alcohol intake into one group.
A mixed effects model with explanatory variables age, calendar time, and gender and a random intercept and slope for age, and first-order autoregressive covariance structure was performed to predict the annual age-related decrease in height.
Predicted 10-year risk of incident AF was calculated for both the observation period and the forecast period (2017-2060). These predictions are based on the assumption of ceteris paribus-all other things held constant-only height is allowed to change. A FineGray model for men with adjustment for age and height was used for prediction. Age was kept fixed, but height varied with the Danish population height based on records from military screening. Seventy-five year old men had an average height of 169 -3.9 = 165.1 cm in 1976 since the height of 18 year old men in 1919 was 169 cm, and the average decrease in height between the age of 18 and 75 was 0.068 cm per year. Similarly, the average 75 years old male height was 173.5 -3.9 = 169.6 cm in 2003 since the average height in 1946 was 173.5 cm.
The misspecification of the functional form of the continuous covariates and the assumption of proportionality in the Fine and Gray subdistribution hazards model was tested based on cumulative sums of residuals. 35 P-values below 0.05 were considered statistically significant. Statistical analyses were performed with R version 3.2.0 (http://cran.rproject.org/).
Results
Population results
Generally, with increasing survey number, participants in both genders were older, taller, more likely to use blood pressure medication, less likely to be smokers, had more years in school, were more physically active in leisure-time, had a higher BMI and FEV 1 percent predicted, and more were likely to have diabetes and a history of IHD or HF (Supplementary material online, Table S2 ).
Development in occurrence of atrial fibrillation
The prevalence and incidence rates of AF increased significantly during follow-up (both P < 0.001) ( Table 1) , and the latter seems aligned with the entire Danish population, at the same time period. 33 The prevalence of AF increased from the first to the fourth survey from 1.35% to 2.11% in men and 0.67% to 1.07% in women. There was a four-fold increase (HR 4.16, 95% CI 3.27-5.29; P < 0.001) in the risk of incident AF for the fourth survey compared to the first survey in both men and women, as no interaction was present (P = 0.09). Non-responders without previous admissions for AF had the same risk of incident AF (HR 0.96, 95% CI 0.70- 1.30 ; P = 0.77) compared to responders at the first survey without previous admissions for AF.
Risk factors for incident atrial fibrillation
Height was a powerful risk factor for incident AF in the multivariable Fine and Gray model with 35-65% higher risk of AF per 10 cm difference in height ( Figure 1 ). There was no interaction between height, sex, and incident AF in any of the four surveys (all P > 0. risk factors for AF were female sex, high blood pressure, blood pressure medication, reduced lung function, never or daily alcohol intake, high BMI, and a history of IHD or HF ( Figure 1 ).
Development in height in the Copenhagen City Heart Study
Supplementary material online, Figure S2 shows secular trends in average height throughout the four surveys between 1976 and 2003 within each 10-year age group for both men and women.
There was an inverse association between height and age. By taken advantage of the repeated measures of height and age, we were able to estimate that the yearly loss of height was about 0.068 cm. Observed developments in height in the Copenhagen City Heart Study were closely aligned with national data. 29 For men height increased 3.3 cm and for women 2.1 cm between the first and fourth examination. This increase yields 11-18% and 6-11% increase in risk of incident AF for men and women, respectively. Here the lowest and highest HRs for height have been used.
Importance of risk factors according to population attributable risk
In general, height ranked as the most important risk factor with PAR between 20 and 30%. Systolic blood pressure showed quite similar results, and sex also seemed to play an important role. The rest of the risk factor had modest or insignificant PAR estimates ( Figure 2) .
Implications for the epidemic of atrial fibrillation Figure 3 shows the secular increase in male population height based on the all-covering national military screening of men at 18 years in Denmark between 1911 and 2014. 29 During these 100 years, the average population height increased 12 cm in Denmark among young men (left y-axis in Figure 3) . The predicted 10-year risk of incident AF is depicted for 70, 75, and 80 years old men, respectively (right y-axis in Figure 3 ). There are no nationwide data on female height covering the same period in time, and therefore we did not perform similar modelling.
Discussion
Main results
There was a four-fold increase in risk of incident AF in both men and women between the first and fourth survey. In the population perspective, height is the most important risk factor for AF. Hazard ratio in the multivariable adjusted models increases significantly by 3-5% for each centimetre of height. In men, increasing population height up to 1990 continues to contribute to increasing incidence of AF for the coming decades.
Incidence and prevalence of atrial fibrillation in the Copenhagen City Heart Study and in Denmark Atrial fibrillation prevalence estimation in the Copenhagen City Heart Study populations sample was based on ECG recordings obtained at the cross-sectional surveys. It is evident that the increase in AF prevalence is real, and not the result of increased diagnostic activity. On the other hand, the assessment of AF incidence, based mainly on register data, show a more marked increased in the same period both in these and national data, suggesting the result of increased clinical awareness and diagnostic activity.
Relationship between height and atrial fibrillation
Height is an important indicator of circulatory burden. Taller subjects have larger heart chamber sizes. Left atrial volume is significantly associated with height even after adjustment for age and gender. 36 As left atrial size is highly associated with risk of AF, 26,37-39 tall stature is naturally associated with AF. 38 Evidently, height is a non-modifiable risk factor.
Possible effects of other risk factors
Ischaemic heart disease and HF are major factors impacting the epidemiology of AF. 40 National data from Denmark indicate that the prevalence of chronic IHD is stable or slightly increasing in spite of marked decreases in incidence of acute coronary syndrome, due to improvements in survival. 9 In the long run, it is likely that the prevalence of IHD will be reduced, but the time course is impossible to foresee. Heart failure is a powerful risk factor with most cases occurring in participants with IHD. Increased blood pressure is also an important risk factor for AF. We have previously reported a significant reduction in population blood pressure. 41 Increased longevity will increase the absolute number of subjects with AF, but the association between height and AF is likely to be unaffected by this.
All in all, we cannot explain a large part of the increase in AF occurrence by changes in other risk factors. As noted above, diagnostic activity most likely plays the major role in this respect.
Developments in height in the Copenhagen City Heart Study and in Denmark
As shown in Supplementary material online, Figure S2 , measured height increased significantly in the Copenhagen City Heart Study sample. The mean increase was about 3 cm over 25 years, slightly more in men than women. The height increase in the Copenhagen City Heart Study is in line with national data. Height measured in conscripts has increased dramatically in the last century. The average height in young male adults in early 20th century was about 169 cm increasing to almost 181 cm in the present century. Secular trends in height in women are not as well documented. However, data from the European Community Household Panel and other sources 28 in height in both genders may be due to improved early life biological health caused by improved nutrition in regard of caloric intake, protein and vitamins, decreased infectious burden, and improvements in preventive health and social equality. 28, 43 The development of male population height as well as the development of AF incidence is shown in Figure 3 . It must be noted that the effect of height on AF occurs about 45 years after adult height is attained, as AF develops in the sixth and later decades of life. Therefore, our present day findings are related to the height as measured in about 1960-1980, while height measured in the 21st century does not impact the risk of AF at the present time. P < 0.10, *P < 0.05, **P < 0.01, ***P < 0.001. CI, confidence interval; FEV 1 , forced expiratory volume in 1 second; HF, heart failure; HR, hazard ratio; IHD, ischaemic heart disease. 
Implications for the epidemic of atrial fibrillation
Predicted increases in risk of AF in relation to observed increases in height appear from Figure 3 . Note that the predicted increases in AF continue until 2060. These data are pertinent to males only. Although height is a powerful risk factor in women as well, the effect of height developments on the occurrence of AF in women is likely to be much smaller, due to the lesser increase in female population height as compared to males.
In Denmark and other European countries, population height peaked around 1990. 28, 29, 44 Dutch men, supposedly the tallest people on the globe, have not increased their height in the last 15 years. 44 Figure 2 Population attributable risk with 15 years of follow-up for each cross-sectional survey. '.' P < 0.10, *P < 0.05, **P < 0.01, ***P < 0.001.
Bootstrap resampling was not feasible for the first survey (1976) (1977) (1978) in column 1. The upper and lower limits of the 95% CI for the hazard ratio (Fine-Gray) were instead inserted as hazard ratios in the estimation of population attributable risk. The significance levels for the first survey were omitted. CI, confidence interval; FEV 1 , forced expiratory volume in 1 second; HF, heart failure; HR, hazard ratio; IHD, ischaemic heart disease; LTPA, leisure-time physical activity. 42 The height in East Asia e.g. Chinese populations is also rapidly increasing. 28 In other countries, such as the USA, the picture is more uncertain, with mixed trends. 45 It has been speculated that the present day population height of Danes and the Dutch is close to the maximally biologically attainable height in human populations. 28 It appears however, that there is a global potential for increases in height, as a major part of the World population in Asia and South America are markedly shorter than Europeans. 28 The American population was previously the tallest in the world but is now surpassed by some European countries by about 4-5 cm. The middle class is rapidly expanding in many countries, 46 and the consequent improved living conditions are likely to result in increasing height as well as increased longevity, at the cost of augmented burden of AF.
Strengths and limitations
The main strength of the Copenhagen City Heart Study is the large, randomly selected population cohort, the long-time and complete follow-up, and the carefully validated diagnoses from the Danish registers. In particular, we have ourselves validated the diagnosis of AF and found acceptable precision. 11 The incidence rates found in the Copenhagen City Heart Study are very similar to national data from the National Institute of Public Health, thus demonstrating that the Copenhagen City Heart Study sample is representative of the Danish population in regard of AF. We have assessed the incidence of AF in non-responders by means of register data and find no difference between responders and non-responders. Height decreases with age. However, using measured height instead of maximally attained height (around age 20), does not lead to conservative results when height decreases linearly with age. In fact, it is just a reparametrization of the same model.
The Copenhagen City Heart Study includes European whites only. Although we cannot exclude different results in other countries, there are no indications that the effect of height on AF in other populations differs from the findings in our cohort.
There is little evidence that the incidence of AF is associated with social status. 47 However, in the fully adjusted model we have included educational level as a possible confounder. We have carefully adjusted for the effects of possible confounders. In observational studies, residual confounding can never be ruled out.
While increased clinical awareness and diagnostic activities related to AF are very likely explanations, it has not been possible to weigh the effects on the observed incidence of AF. We simply do not have the data.
It may also be questioned if subject level associations can be extrapolated to population level changes. The central assumption in a forecast analysis is that risk factors (here height) are causally related to the outcome. An in-depth review of the chain of causality is outside the scope of this manuscript.
Conclusion
Prevalence and incidence of AF have increased markedly during the last four decades. Height is a powerful risk factor for AF, and population height has increased significantly during the last century. We assessed the contribution of increasing height as well as other risk factors to the secular trends in AF incidence. The observed increase in height yields an increase of 6-18% in incident AF risk. Population height as measured in conscripts peaked in about 1990 in Denmark. Adult height is attained at early adulthood, while AF incidence occurs Increasing population height and risk of incident AF around 50 years later. Assuming a causal relationship between height and AF incidence, increased population height in Denmark will contribute to an increase in AF occurrence for at least 25 more years (Take home figure).
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